171 completed, 42 unknown, 29 recruiting, 23 terminated. 46 Phase 3, 33 Phase 4, 32 Phase 2, 27 Not applicable, 19 Phase 1.
Follow Invasive Fungal Infections: new trials by email Literature Review of Invasive Fungal Infections trials Research Report on Invasive Fungal Infections
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase II Randomized Study to Evaluate Measures for Endpoint Derivation in Patients With Progressive or Refractory Disseminated Coccidioidomycosis Treated With Olorofim Plus Baseline Standard of Care or Placebo Plus Baseline Standard of Care Olorofim, Placebo - Coccidioidomycosis, Disseminated Fungal Infection | Phase 2 | Not yet recruiting | F2G Ltd | 50 | 2026-12-01 | 2026-09-22 |
| Emerging Indications for Hyperbaric Oxygen Treatment Hyperbaric oxygen treatment (HBOT), 100% Oxygen - Post-COVID-19 Condition, Ulcerative Colitis | Phase 4 | Not yet recruiting | Jay C. Buckey Jr. | 100 | 2026-11-01 | 2026-09-09 |
| Evaluation of Diagnostic Accuracy and Clinical Performance of the UllCORE Bloodstream Infection (BSI) Test UllCORE BSI Test - Blood Stream Infection, Blood Stream Infections | Recruiting | Deepull Diagnostics S.L. | 1500 | 2026-09-21 | 2026-10-08 | |
| Shortening Treatment Duration in Uncomplicated Candidemia: the CanTEN Trial Caspofungin only within the study, Caspofungin for 3 days within the study, Placebo only within the study - Candidemia, Invasive Candidiasis | Phase 4 | Not yet recruiting | Oliver Cornely, MD | 420 | 2026-09-01 | 2026-09-01 |
| mNGS for IFD in Patients With Hematological Malignancies metagenomic next-generation sequencing - Hematological Malignancies, Invasive Fungal Disease | Not yet recruiting | Nanfang Hospital, Southern Medical University | 50 | 2026-08-10 | 2026-08-13 | |
| Liposomal Amphotericin B for Invasive Fungal Disease in Solid Organ Transplant Recipients Liposomal Amphotericin B, Alternative Systemic Antifungal Therapy - Invasive Fungal Infection, Solid Organ Transplantation | Not yet recruiting | Sichuan Provincial People's Hospital | 120 | 2026-07-01 | 2026-06-24 | |
| Amphotericin B for Breakthrough Fungal Infections After Triazole Prophylaxis in Hematological Patients Amphotericin B - Invasive Fungal Disease | Not applicable | Not yet recruiting | Peking University People's Hospital | 15 | 2026-04-01 | 2026-04-30 |
| Study on the Pharmacokinetic Characteristics of Liposomal Amphotericin B in Patients With Invasive Fungal Infections Undergoing Plasma Exchange Therapy Collection of pharmacokinetic samples to explore the pharmacokinetic characteristics in severe invasive fungal infection patients receive liposomal amphotericin B who undergo plasma exchange therapy. - Invasive Fungal Infections | Not yet recruiting | Institute of Hematology & Blood Diseases Hospital, China | 10 | 2026-03-30 | 2026-04-16 | |
| Low-Dose Liposomal Amphotericin B for Invasive Fungal Infection Prophylaxis in Neutropenic Children Liposomal Amphotericin B (LAmB) - Thalassemia, Hematopoietic Stem Cell Transplantation | Recruiting | Haikou Affiliated Hospital of Central South University Xiangya School of Medicine | 30 | 2026-02-01 | 2026-07-24 | |
| Clinical Efectiveness of a Multiplex PCR-Based Rapid Diagnostic Method in Bloodstream Infections Multiplex PCR-Based Rapid Diagnostic Test, Standard Microbiological Diagnostic Methods - Bloodstream Infections, Bacteremia and Sepsis | Recruiting | Istanbul Medipol University Hospital | 300 | 2026-01-01 | 2026-02-13 | |
| Derivation and Validation of the Fungal Pneumonia Assessment and Likelihood Predictor Score FUNGAL-P Score Assessment - Pneumonia, Fungal Pneumonia | Recruiting | Azienda Ospedaliero-Universitaria Careggi | 400 | 2025-11-13 | 2026-07-02 | |
| Influenza A-associated Pulmonary Aspergillosis in Patients Admitted to the Intensive Care Unit in China IPA and non-IPA groups - ICU, Invasive Pulmonary Aspergillosis | Completed | Jianfeng Xie | 542 | 2025-11-01 | 2026-01-09 | |
| A Real-world Prospective Observational Study on the Efficacy and Safety of L-AmB(Liposomal Amphotericin B) for br- IFD(Breakthrough Invasive Fungal Disease) in Children and Adolescent Patients With Hematological Malignancies Receiving Triazoles or Echinocandins Prophylaxis Patients received the Drug: liposomal amphotericin B(AmBisome) for treatment - Fungal Disease | Recruiting | Institute of Hematology & Blood Diseases Hospital, China | 38 | 2025-09-30 | 2026-01-21 | |
| Liver Cirrhosis Patients With Invasive Pulmonary Aspergillosis: in Depth Understanding Clinical Host Risk Factors Liver Cirrhosis, Viral Pneumonia | Active not recruiting | Universitaire Ziekenhuizen KU Leuven | 450 | 2025-08-01 | 2026-03-04 | |
| Low-dose Liposomal Amphotericin B for Antifungal Prophylaxis in Prolonged Neutropenia Patients Liposomal Amphotericin B - Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia | Recruiting | Haikou Affiliated Hospital of Central South University Xiangya School of Medicine | 30 | 2025-08-01 | 2026-11-20 | |
| Immunomonitoring of Mold Invasive Infections Invasive Fungal Disease, Mold Invasive Fungal Infection: Aspergillus, Mucorales, Fusarium, Scedosporium | Recruiting | Assistance Publique - Hôpitaux de Paris | 20 | 2025-07-28 | 2025-11-20 | |
| Fungal Status and Prognosis in ABPA ABPA, Allergic Bronchopulmonary Aspergillosis | Recruiting | Qianfoshan Hospital | 114 | 2025-07-01 | 2026-07-08 | |
| A Randomized Study of a Short Duration Therapy for Candidemia Standard of Care (SOC), Shortened duration of antifungal therapy - CANDIDEMIA | Phase 3 | Not yet recruiting | Assistance Publique - Hôpitaux de Paris | 362 | 2025-07-01 | 2025-03-05 |
| Human Bioequivalence Study of Liposomal Amphotericin B for Injection Test product (Liposomal amphotericin B for injection, Sichuan Huiyu Pharmaceutical Co., Ltd.), Reference product (AmBisome®, Astellas Pharma US Inc.) - Invasive Fungal Infections, Neutropenic Fever | Not applicable | Completed | Sichuan Huiyu Pharmaceutical Co., Ltd | 58 | 2025-05-25 | 2026-05-27 |
| Liposomal Amphotericin B and Isavuconazole/Posaconazole in Br-IFD( Breakthrough Invasive Fungal Disease) in Patients With Malignant Hematological Diseases Invasive Fungal Disease | Recruiting | Institute of Hematology & Blood Diseases Hospital, China | 36 | 2025-05-19 | 2025-08-22 |
Showing 20 of 289. Sign in to see all of them.
Candidemia (69) · Candidiasis, Invasive (64) · Mycoses (53) · Invasive Pulmonary Aspergillosis (43) · Candidiasis (37) · Fungemia (30) · Aspergillosis (24) · Torulopsis (22) · Hematologic Neoplasms (16) · Sepsis (14) · Neutropenia (13) · Bacteremia (12) · Critical Illness (8) · Leukemia (7)
Bacterial Infections and Mycoses (289) · Infections (288) · Mycoses (236) · Pathological Conditions, Signs and Symptoms (112) · Pathologic Processes (108) · Inflammation (90) · Systemic Inflammatory Response Syndrome (89) · Candidiasis (80) · Sepsis (77) · Fungemia (61) · Respiratory Tract Diseases (50) · Lung Diseases (49) · Lung Diseases, Fungal (45) · Candidiasis, Invasive (41)
Micafungin (32) · Caspofungin (26) · Voriconazole (25) · Fluconazole (20) · Anidulafungin (17) · liposomal amphotericin B (15) · Amphotericin B (12) · Injections (9) · isavuconazole (8) · posaconazole (7) · Blood Specimen Collection (5) · Itraconazole (5) · ibrexafungerp (5) · olorofim (5) · Rezafungin (3)
Pfizer (22) · Astellas Pharma Inc (13) · Merck Sharp & Dohme LLC (10) · Radboud University Medical Center (9) · National Cancer Institute (NCI) (7) · Basilea Pharmaceutica (6) · University Hospital, Lille (6) · Scynexis, Inc. (5) · Universitaire Ziekenhuizen KU Leuven (5) · Asan Medical Center (4) · Assistance Publique - Hôpitaux de Paris (4) · Astellas Pharma Global Development, Inc. (4) · F2G Ltd (4) · Institute of Hematology & Blood Diseases Hospital, China (4) · Medical University of Graz (4)
United States (76) · France (50) · China (44) · Italy (32) · Germany (31) · Belgium (28) · Spain (28) · Netherlands (25) · Canada (20) · South Korea (20) · Israel (16) · United Kingdom (16) · Austria (15) · Australia (14) · Brazil (14)
David Angulo, MD (4) · Marc Engelhardt (4) · Robert Krause, MD (3) · Joost Wauters, MD, PhD (2) · Peter G Pappas, MD (2) · Peter Pappas, MD (2) · Qing Wen (2) · William J Steinbach, MD (2) · Aiming Pang, doctor (1) · Alberto M Borobia, MD, PhD (1)
PMID 28459966, PMID 28597967, PMID 33891293, PMID 31280481, PMID 21147825, PMID 23315320, PMID 26969258, PMID 33438477, PMID 37185921, PMID 38008099, PMID 38502709, PMID 39468640, PMID 39529079, PMID 41940006, PMID 10394018, PMID 10394019, PMID 11561801, PMID 12145716, PMID 12729424, PMID 1542320, PMID 16127033, PMID 16436724, PMID 17568028, PMID 17719934, PMID 19473094, PMID 19485785, PMID 19804626, PMID 21565903, PMID 21729932, PMID 21854805, PMID 22018278, PMID 22469884, PMID 22814329, PMID 22879929, PMID 22955439, PMID 23676114, PMID 23710653, PMID 24165173, PMID 24261608, PMID 24550378, PMID 24559321, PMID 24669841, PMID 24906361, PMID 24948702, PMID 25040144, PMID 25097069, PMID 25139840, PMID 25149761, PMID 25203869, PMID 25293517
2008 (4), 2017 (4), 2019 (3), 2009 (2), 2015 (2), 2014 (1), 2018 (1), 2023 (1), KL2TR000136 (1), R01AI139032 (1), R01AI170385 (1), U01CK000692 (1), U10CA095861 (1), UG1CA189955 (1), UM1AI104681 (1)